Contemporary Medical Management of Systolic Heart Failure

Pharmacological therapy of systolic left ventricular dysfunction has evolved over the past 3 decades. Current therapy is focused primarily on the regulation of the renin-angiotensin-aldosterone axis and sympathetic nervous system. Additional targets of pharmacotherapy include vasoconstriction, impai...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation Journal 2012, Vol.76(2), pp.268-277
Hauptverfasser:	Nair, Ajith P., Timoh, Tendoh, Fuster, Valentin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Angiotensin II Type 1 Receptor Blockers - therapeutic use Angiotensin receptor blockers Angiotensin-converting enzyme inhibitors Angiotensin-Converting Enzyme Inhibitors - therapeutic use Beta-blockers Heart failure Heart Failure, Systolic - drug therapy Heart Failure, Systolic - physiopathology Humans Renin-Angiotensin System - drug effects Renin-Angiotensin System - physiology Sympathetic activation Sympathetic Nervous System - drug effects Sympathetic Nervous System - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!